08/06/2024

News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

08/06/2024

Jun 8, 2024, 10:07 | Insight
Ari Rosenberg: Our OPTIMA II trial is out in JAMA Oncology
Ari Rosenberg, Medical Oncologist and Assistant Professor at the University of Chicago, shared a post…
Jun 8, 2024, 09:58 | Insight
Angelo Pirozzi: Circulating immune-related proteins might predict the efficacy of Immune Checkpoint Inhibitors
Angelo Pirozzi, Research Fellow at Mayo Clinic, shared on X:          .…
Jun 8, 2024, 09:52 | Opinion
The ACS, NCI and CRUK are launching their first annual conference
The NCI Division of Cancer Prevention shared on LinkedIn: "Last call to register! The American…
Jun 8, 2024, 09:47 | Blog
Angela Mastronuzzi: Today and every June 8th, we honor World Brain Tumor Day
Angela Mastronuzzi shared a post on LinkedIn: “Today and every June 8th, we honor World Brain…
Jun 8, 2024, 09:44 | Societies
If your goal is networking and collaboration, then you should attend the SIOP congress
SIOP shared on LinkedIn: "If your goal is networking and collaboration on an international level,…
Jun 8, 2024, 09:37 | Societies
Onyinye Balogun: Attending OncoDaily Yvonne Awards 2024 was certainly one of my ASCO24 highlights!
Onyinye Balogun, Co-Founder of Mission-Driven Tech, shared on LinkedIn: "Attending OncoDaily Yvonne Awards 2024 was…
Jun 8, 2024, 09:27 | Blog
Zainab Shinkafi-Bagudu: I am honoured to Chair the Women’s Health Cervical Cancer Session on June 8th
Zainab Shinkafi-Bagudu shared on LinkedIn: "Joining the 2024 Global Health Catalysts Summit from June 7-9…
Jun 8, 2024, 08:22 | Blog
Michel Ducreux and Teresa Macarulla discussing GI Cancer research on ESMO Daily Reporter
ESMO shared on LinkedIn: "Whilst neoadjuvant chemotherapy is now a well-established strategy for treating some…
Jun 8, 2024, 07:23 | Opinion
Benjamin Toll: Interesting study about nausea prevention with olanzapine
Benjamin Toll, Associate Director of Education at MUSC Hollings Cancer Center, shared a post on…
Jun 8, 2024, 06:59 | Blog
Results of the NICHE-2 trial show it to be highly effective in a subset of patients with colon cancer - The Netherlands Cancer Institute
The Netherlands Cancer Institute shared on Linkedin: “More succes for neoadjuvant immunotherapy: results of the…
All: 60 Posts: 31 - 40
Special Coverage